DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $304,000 | +46.2% | 8,149 | 0.0% | 0.14% | +30.5% |
| Q1 2021 | $208,000 | +1.0% | 8,149 | +0.3% | 0.10% | -26.1% |
| Q2 2020 | $206,000 | -5.1% | 8,127 | -17.3% | 0.14% | -15.0% |
| Q4 2019 | $217,000 | +49.7% | 9,829 | -2.9% | 0.17% | +29.5% |
| Q3 2019 | $145,000 | -29.3% | 10,121 | -22.4% | 0.13% | -31.7% |
| Q2 2019 | $205,000 | +7.3% | 13,044 | 0.0% | 0.19% | 0.0% |
| Q1 2019 | $191,000 | -4.0% | 13,044 | 0.0% | 0.19% | +18.9% |
| Q4 2018 | $199,000 | – | 13,044 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |